Prosecution Insights
Last updated: October 25, 2026

Syndicated Law Pc

Technology area: Biotechnology & Pharmaceuticals

8 pending office actions • 6 clients • 8 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Syndicated Law PC has 386 career applications in Biotechnology & Pharmaceuticals and 9 pending office actions. The record reflects an established application history alongside a current office-action docket that remains active.

The resolved allowance rate is 90.13%, and the average is 2.78 office actions per allowance. The outcome measure shows that resolved matters have commonly reached allowance, while the activity measure indicates that allowances generally followed more than one office-action event.

Practitioners can use the profile to evaluate both reported results and the level of prosecution interaction associated with allowances. The data does not explain differences among applications, claim strategies, or examiner treatment, so it should be used as a screening tool rather than a matter-specific prediction.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=386 apps, methodology: how we score firms)

90.1%
Allowance Rate
n=386
+0.99σ
Allowance Rate (norm)
n=386
2.8
OAs to Allowance
n=283
-0.47σ
OAs to Allow (norm)
n=283
874 days
Time to Allowance
n=283
+9.3pp
Interview Lift
n=386
21.3%
RCE Rate
n=386
0.4%
Appeal Rate
n=386

Rejection Performance (% of received rejections ultimately overcome)

84.6%
§101 Overcome
n=39
86.9%
§102 Overcome
n=84
91.2%
§103 Overcome
n=159
87.2%
§112 Overcome
n=172

Specialization & Scale

A61K, A61P, G06Q
Top CPC Subclasses
28%
Top-3 CPC Share
n=386
1
Practitioners
n=386
386.0
Apps / Practitioner
n=386

Portfolio Summary

8
Total Pending OAs
4
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (62%)
1
Medium (12%)
1
Easy (12%)
1
Unknown (12%)

Rejection Statute Mix

BucketCases
§101 + other1 (12%)
§112 only1 (12%)
Double-patenting + other1 (12%)
Multi-statute (no §101)4 (50%)
No statute on record1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
75% of docket
2
Information Tech
25% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MERCADO VARGAS, ARIEL 1 71.5% +28.3%
COX, NATISHA D 1 72.9% +21.4%
BRANDSEN, BENJAMIN MICHAEL 1 60.9% +21.7%
TAKENAKA, RISA 1 26.1% +100.0%
HIBSHMAN, SARAH GRACE 1 38.2% +40.7%
TINSLEY, BRENDAN THOMAS 1 60.4% +74.3%
ROGERS, ERIC JASON 1 56.9% +33.2%
PENNINGTON, KATIE LEIGH 1 31.8% +58.8%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17800307 METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD ROGERS, ERIC JASON 112d overdue
18561083 METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN BRANDSEN, BENJAMIN MICHAEL —
18027892 CELL POPULATION PRODUCTION METHOD TAKENAKA, RISA —
18001994 BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE HIBSHMAN, SARAH GRACE —
17801102 BIOMATERIAL PRESERVING COMPOSITION TINSLEY, BRENDAN THOMAS —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17800307 METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD ROGERS, ERIC JASON 112d overdue
18766372 Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction COX, NATISHA D 70d
18780967 USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS MERCADO VARGAS, ARIEL —
18561083 METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN BRANDSEN, BENJAMIN MICHAEL —
18027892 CELL POPULATION PRODUCTION METHOD TAKENAKA, RISA —
18001994 BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE HIBSHMAN, SARAH GRACE —
17801102 BIOMATERIAL PRESERVING COMPOSITION TINSLEY, BRENDAN THOMAS —
17601861 CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY PENNINGTON, KATIE LEIGH —

Client Portfolio (6 clients)

Top Art Units

Art UnitApps
16932
16342
21181
24581
16321
16381

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18780967 USING A PACE SETTING PERFORMANCE TO ASSEMBLE A PLURALITY OF PERFORMANCES RECEIVED FROM REMOTE LOCATIONS Jammit, Inc. MERCADO VARGAS, ARIEL 2118 §112DP Non-Final OA — Pending Jul 23, 2024
18766372 Systems and Methods for Assembling Remote Members of an Online Gaming Environment for a Group Interaction Turion Corporation COX, NATISHA D 2458 §112 Non-Final OA 70d Pending Jul 08, 2024
18561083 METHOD FOR PRODUCING BETA-1,3-1,6-GLUCAN National University Corporation Kochi University BRANDSEN, BENJAMIN MICHAEL 1693 §101§102§112DP Non-Final OA — Pending Nov 15, 2023
18027892 CELL POPULATION PRODUCTION METHOD Gn Incorporation Co. Ltd. TAKENAKA, RISA 1632 §102§103§112 Final Rejection — Pending Mar 22, 2023
18001994 BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING, AND FOR ADJUVANT USE Sophy Inc. HIBSHMAN, SARAH GRACE 1693 §102§103§112 Final Rejection — Pending Dec 15, 2022
17801102 BIOMATERIAL PRESERVING COMPOSITION Gn Corporation Co. Ltd. TINSLEY, BRENDAN THOMAS 1634 §102§103§112 Final Rejection — Pending Aug 19, 2022
17800307 METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD Gn Corporation Co. Ltd. ROGERS, ERIC JASON 1638 §102§112 Final Rejection 112d overdue Pending Aug 17, 2022
17601861 CHONDROCYTE CULTURE WITH HIGH TISSUE REGENERATION ABILITY Jbm Incorporation PENNINGTON, KATIE LEIGH 1634 Other Non-Final OA — Pending Oct 06, 2021

Managing Syndicated Law Pc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Syndicated Law Pc's patent allowance rate?

90.1% of resolved applications prosecuted by Syndicated Law Pc were allowed, across 386 applications in USPTO records.

How many office actions does Syndicated Law Pc average before allowance?

2.78 office actions per allowed application on average.

How many pending office actions does Syndicated Law Pc have?

8 pending office actions as of October 2026, for 6 clients, before 8 examiners in 6 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month